1 December 2022
Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial.
Dayyeh PKA, Bazerbachi F, Vargas EJ, Sharaiha RZ, Thompson CC, Thaemert BC et al, for the MERIT Study Group.
Lancet 2022; 400: 441-451.
After one year, mean percentage excess weight loss was 49.2 per cent after sleeve gastrectomy compared to 3.2 per cent in controls, P<0.0001, in this study that included 209 patients. There were only three serious adverse events (2 per cent) after surgery.
Comment: Strong evidence for benefit from sleeve gastrectomy in the short term.
26 October 2022Read paper
Part of the charitable activity of the Society, BJS Academy is an online educational resource for current and future surgeons.
The Academy is comprised of five distinct sections: Continuing surgical education, Young BJS, Cutting edge, Scientific surgery and Surgical news. Although the majority of this is open access, additional content is available to BJS subscribers and strategic partners.